| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
TSE:MSCL
Satellos Bioscience
|
Sep 30, 2026 | BUY |
Strong Buy
+155.3% avg upside
8 analysts
|
$31.33
159.15% Upside
|
· | · |
|
DYN
Dyne Therapeutics
|
Sep 30, 2026 | BUY |
Buy
+135.6% avg upside
31 analysts
|
$40.00
152.87% Upside
|
· | · |
|
DRUG
Bright Minds Biosciences
|
Sep 28, 2026 | BUY |
Strong Buy
+173.1% avg upside
11 analysts
|
$146.00
196.60% Upside
|
· | · |
|
LRMR
Larimar Therapeutics
|
Sep 28, 2026 | BUY |
Strong Buy
+484.1% avg upside
22 analysts
|
$25.00
717.08% Upside
|
· | · |
|
DFTX
Definium Therapeutics
|
Sep 19, 2026 | BUY |
Strong Buy
+39.9% avg upside
23 analysts
|
$78.00
107.44% Upside
|
-4.8% | · |
|
AQST
Aquestive Therapeutics
|
Sep 17, 2026 | BUY |
Strong Buy
+101.0% avg upside
10 analysts
|
$10.00
125.29% Upside
|
+0.2% | · |
|
IRD
Opus Genetics
|
Sep 12, 2026 | BUY |
Strong Buy
+157.3% avg upside
25 analysts
|
$20.00
343.48% Upside
|
-18.9% | · |
|
APMD
Apnimed, Inc.
|
Sep 09, 2026 | BUY |
Strong Buy
+123.4% avg upside
4 analysts
|
$50.00
121.90% Upside
|
-22.0% | · |
|
CMPS
COMPASS Pathways
|
Sep 09, 2026 | BUY |
Strong Buy
+84.9% avg upside
20 analysts
|
$24.00
100.87% Upside
|
-12.8% | · |
|
OVID
Ovid Therapeutics
|
Aug 14, 2026 | BUY |
Strong Buy
+112.3% avg upside
18 analysts
|
$5.00
105.86% Upside
|
-14.1% | · |
|
MPLT
MapLight Therapeutics, Inc.
|
Aug 14, 2026 | BUY |
Strong Buy
+201.0% avg upside
13 analysts
|
$37.00
284.14% Upside
|
-13.3% | · |
|
SVRA
Savara
|
Aug 12, 2026 | BUY |
Strong Buy
+71.5% avg upside
17 analysts
|
$10.00
98.22% Upside
|
-12.3% | · |
|
PRAX
Praxis Precision Medicines
|
Aug 08, 2026 | BUY |
Strong Buy
+95.3% avg upside
24 analysts
|
$754.00
162.82% Upside
|
-20.2% | · |
|
TARS
Tarsus Pharmaceuticals
|
Aug 08, 2026 | BUY |
Strong Buy
+9.8% avg upside
17 analysts
|
$104.00
37.86% Upside
|
+13.4% | · |
|
KALA
KALA BIO
|
Oct 24, 2025 | HOLD |
Strong Buy
+48122.9% avg upside
9 analysts
|
— | -98.9% | · |
|
HRMY
Harmony Biosciences Holdings
|
Apr 08, 2025 | BUY |
Strong Buy
+24.9% avg upside
14 analysts
|
$61.00
54.06% Upside
|
+1.2% | · |
|
SLP
Simulations Plus
|
Apr 04, 2025 | BUY |
Buy
+104.9% avg upside
11 analysts
|
$65.00
251.54% Upside
|
-53.3% | · |
|
FTH
Faeth Therapeutics
|
Mar 28, 2025 | BUY |
Strong Buy
+69.7% avg upside
20 analysts
|
$80.00
182.93% Upside
|
+172.4% | · |
|
ABEO
Abeona Therapeutics
|
Mar 20, 2025 | BUY |
Strong Buy
+239.6% avg upside
18 analysts
|
$16.00
219.32% Upside
|
-13.4% | · |
|
ALDX
Aldeyra Therapeutics
|
Mar 03, 2025 | BUY |
Strong Buy
+1181.0% avg upside
21 analysts
|
$12.00
830.23% Upside
|
-15.7% | · |
|
TRDA
Entrada Therapeutics Inc
|
Feb 28, 2025 | BUY |
Strong Buy
+266.7% avg upside
10 analysts
|
$30.00
428.12% Upside
|
-0.1% | · |
|
ACHV
Achieve Life Sciences
|
Jan 08, 2025 | BUY |
Strong Buy
+104.5% avg upside
16 analysts
|
$11.00
46.02% Upside
|
+55.4% | · |
|
HELP
Helus Pharma
|
Aug 26, 2024 | HOLD |
Strong Buy
+213.5% avg upside
14 analysts
|
— | -26.6% | · |
|
BCRX
BioCryst
|
Aug 26, 2024 | HOLD |
Strong Buy
+122.9% avg upside
24 analysts
|
— | +4.2% | · |
|
MDWD
Mediwound
|
Jul 29, 2024 | BUY |
Strong Buy
+60.3% avg upside
13 analysts
|
$36.00
164.79% Upside
|
+2.4% | · |
|
DMAC
Diamedica Therapeutics
|
Jul 01, 2024 | BUY |
Strong Buy
+81.2% avg upside
12 analysts
|
$6.00
28.13% Downside
|
+21.0% | · |
|
BNGO
BioNano Genomics
|
Aug 17, 2023 | BUY |
Buy
+503.0% avg upside
9 analysts
|
$20.00
1173.92% Upside
|
· | · |
|
PCSA
Processa Pharmaceuticals
|
Apr 03, 2023 | BUY |
Strong Buy
+2622.4% avg upside
5 analysts
|
$60.00
3603.75% Upside
|
· | · |
|
SERA
Sera Prognostics
|
Mar 23, 2023 | BUY |
Strong Buy
+265.2% avg upside
8 analysts
|
$5.00
145.03% Upside
|
+163.8% | · |
|
NMTRQ
9 Meters Biopharma
|
Sep 27, 2022 | BUY |
Buy
+3234374900.0% avg upside
11 analysts
|
$100.00
9999999900.01% Upside
|
· | · |
|
MDXH
MDxHealth
|
Jul 18, 2022 | BUY |
Strong Buy
+936.0% avg upside
9 analysts
|
$18.00
3023.99% Upside
|
-48.5% | · |
|
CELC
Celcuity
|
May 11, 2020 | BUY |
Strong Buy
+65.5% avg upside
17 analysts
|
— | +405.3% | · |
|
EOCN
Eocene
|
Feb 04, 2020 | BUY |
Buy
+613.2% avg upside
13 analysts
|
$18.00
428.62% Upside
|
· | · |
|
TLSA
Tiziana Life Sciences
|
Sep 10, 2019 | BUY |
Strong Buy
+495.7% avg upside
6 analysts
|
$4.00
250.85% Upside
|
+136.0% | · |
|
EBS
Emergent Biosolutions
|
Sep 04, 2019 | BUY |
Buy
+290.4% avg upside
9 analysts
|
$72.00
1030.28% Upside
|
+87.1% | · |
|
ARDS
Aridis Pharmaceuticals
|
Sep 04, 2019 | BUY |
Strong Buy
+13249900.0% avg upside
5 analysts
|
$15.00
14999899.97% Upside
|
· | · |
|
SDEV
Stablecoin Development Corp
|
Jul 29, 2019 | HOLD |
Buy
-64.8% avg upside
7 analysts
|
$1.00
72.66% Downside
|
· | · |
|
MTVA
MetaVia
|
Jun 27, 2019 | BUY |
Strong Buy
+1835.8% avg upside
13 analysts
|
$50.00
3146.78% Upside
|
· | · |
|
STEX
Streamex
|
Feb 20, 2019 | BUY |
Strong Buy
+1269.1% avg upside
5 analysts
|
$10.50
1614.92% Upside
|
· | · |
|
TVRD
Tvardi Therapeutics
|
May 24, 2018 | BUY |
Strong Buy
+1298.9% avg upside
24 analysts
|
$26.00
1996.75% Upside
|
· | · |
|
HEPA
Hepion Pharmaceuticals
|
Feb 13, 2018 | BUY |
Strong Buy
+47841.0% avg upside
9 analysts
|
$210.00
209900.04% Upside
|
· | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.